Characterising Patient Pathways to the Diagnosis of Idiopathic Pulmonary Fibrosis: Real World Data Study

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS20994
• Study ID:
  30193
• Official title and acronym:
  Characterising Patient Pathways to the Diagnosis of Idiopathic Pulmonary Fibrosis: Real World Data Study
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  An exploratory historical UK database study characterising patient pathways to diagnosis of IPF, identifying and quantifying blocks and red flags through primary, secondary, and tertiary care settings.
• Study status:
  Finalised

Research institutions and networks

Institutions

Observational & Pragmatic Research Institute Pte (OPRI)

United Kingdom

Study timelines

Date when funding contract was signed

Planned:28/06/2017

Actual:28/06/2017

Study start date

Planned:01/06/2018

Actual:07/07/2018

Date of final study report

Planned:31/08/2018

Actual:28/08/2018

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Roche

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable